Studies Found: 14
A Study to Help People Quit Smoking
Tobacco use is the leading cause of death and disability in the U.S. that is preventable. Just-In-Time is a tool developed for preventing and treating addictions. Research is needed to know the effectiveness of the tool. The information we learn may aid future patients. (IRB#: IRB_00112287)
Assess the Science to Stop Smoking
Tobacco is related to at least 20 different cancers. Most attempts to quit smoking fail. Technology has been developed to better understand how a persons emotions impact people in their efforts. Research is needed to assess the support people need to stop smoking. The information we learn may aid future patients. (IRB#: IRB_00104596)
Cancer Stories Shaping Outcomes Can Your Cellphone Be a Compassionate Listener?
This study is looking at cancer patient voices, actions and body language using computer measurements of behavior via video-recorded answers to questions on your smartphone device using a free app. This research is important because it may help us discover and understand unknown factors that impact cancer treatment outcomes. (IRB#: IRB_00143135)
A study to evaluate the safety and efficacy of Alpha 1 Antitrypsin for the prevention of graft versus host disease in patients receiving hematopoietic cell transplant (IRB#: IRB_00125273)
CTL019: A Study Drug for Pediatric Patients with Recurring B-Cell Acute Lymphoblastic Leukemia (ALL)
Acute lymphoblastic leukemia (ALL) is the most common form of pediatric leukemia. CTLO19 is a study drug for children with recurring B-Cell ALL. Research is needed to learn the safety and effectiveness of the study drug. The information we gain may aid future patients. (IRB#: IRB_00078083)
The description and purpose of the study drug is to research the use of an investigational product labeled NA- IP (DAY 101- formerly TAK-580/MLN2480) to treat Low-Grade Glioma and other advanced solid tumors in pediatric and age-of-majority participants (IRB#: IRB_00138633)
HCI-Total Cancer Care Study
This study is a partnership between participants, health care providers, and researchers. Our aim is to better understand what causes cancer and to find better ways to prevent, detect, and treat cancer more successfully while also supporting your family.
This study is an opportunity to contribute samples and information that will be used to accelerate cancer research and improve patient care. Participants like you are vital to our success.
The study also offers access to a broader set of clinical trials and new treatments through our partnership with other leading cancer centers nationally. There is no cost to be in this study.
No matter what you decide, it won't change the relationship with your health care providers to affect the quality of your care. (IRB#: IRB_00089989)
Long-Term Follow-Up of Patients Who Received Lentiviral-Based CAR-T Cell Therapy
People with specific types of cancer such as leukemia and lymphomas may receive Lentiviral-Based CAR-T Cell Therapy. This is to help improve the symptoms of this disease. Research is needed to learn the long-term safety and effectiveness of the therapy. The information we gain may provide further guidance to patients, doctors, and researchers. (IRB#: IRB_00079262)
Personalized Survival Data for Decision Making in the Cancer Journey
We need your help to explore patient and caregiver needs when making decisions about new cancer treatment with an oncologist. (IRB#: IRB_00131189)
PNOC-013 Study of Single Agent REGN2810 in Pediatric Patients with Relapsed or Refractory Solid or Central Nervous System (CNS) Tumors and a Safety and Efficacy Trial of REGN2810 in Combination with Radiotherapy in Pediatric Patients
This study is being done to test if cemiplimab (study drug-REGN2810) can reduce the size of a tumor by helping the immune system destroy the tumor. The study is also being done to test the safety of cemiplimab in pediatric patients. (IRB#: IRB_00109601)
Skin Cancer Prevention Education for Pregnant Mothers and Their New Babies
Skin cancer is the most commonly diagnosed cancer in the United States. Parents are important in their childrens sun safety. Research is needed to find out how possible and effective it is to provide sun protection education to pregnant mothers. While studying the effects of the mothers sun protection actions. The information we learn will aid future patients. (IRB#: IRB_00150970)
Tisagenlecleucel (CTLO19): A Drug for People with Acute Lymphoblastic Leukemia (ALL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) is a cancer of the blood and bone marrow. CTLO19 is a drug to help people with this disease. Some patients do not meet the guidelines to get the drug. Research is needed for these patients to receive CTLO19. The information we learn may aid future patients. (IRB#: IRB_00115875)
Ultraviolet Ray Prevention for Children
Melanoma is the 6th most common type of skin cancer in the United States. The just-in-time intervention (JITAI) application (app) is a tool used on a cell phone. The tool can help children and adults know how much time in ultraviolet rays (UVL) from the sun. Research is needed to learn what children and adults think about using the JITAI app. We hope to reduce the time children spend in UVR, so sunburns occur less. (IRB#: IRB_00121617)
Venetoclax: A Study Drug for Children and Young Adults with Resistant or Reoccurring Types of Leukemia or other Specific Cancer
Children and young adults may have resistant and reoccurring types of Leukemia or other specific cancer. Venetoclax is a study drug for these types of cancer. Research is needed to learn how well Venetoclax works with and without chemotherapy. The information we learn may aid future patients. (IRB#: IRB_00103319)